Showing 1 - 1 results of 1 for search 'Deva Mahalingam', query time: 0.01s Refine Results
  1. 1
    Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies

    Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies by Syed Kazmi, Lijun Sun, Justin Moser, Angela Alistar, Timothy A Yap, Edward Garmey, Teresa Mooneyham, Peter Vu, Jay Jacoby, Deva Mahalingam

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: